Evidence map›Paper›PMID 32824414›Full record

ArticleCancers2020

No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy-A Meta-Analysis of Randomized Trials.

Jan Haussmann, Wilfried Budach, Stefanie Corradini, David Krug, Balint Tamaskovics, Edwin Bölke, Freddy-Joel Djiepmo-Njanang, Ioannis Simiantonakis, Kai Kammers, Christiane Matuschek

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jan HaussmannDepartment of Radiation Oncology, Heinrich Heine University, 40225 Duesseldorf, Germany.
Wilfried BudachDepartment of Radiation Oncology, Heinrich Heine University, 40225 Duesseldorf, Germany.
Stefanie CorradiniDepartment of Radiation Oncology, LMU University, 81377 Munich, Germany.ORCID 0000-0001-8709-7252
David KrugDepartment of Radiation Oncology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
Balint TamaskovicsDepartment of Radiation Oncology, Heinrich Heine University, 40225 Duesseldorf, Germany.ORCID 0000-0002-2533-0167
Edwin BölkeDepartment of Radiation Oncology, Heinrich Heine University, 40225 Duesseldorf, Germany.ORCID 0000-0001-9112-1024
Freddy-Joel Djiepmo-NjanangDepartment of Radiation Oncology, Heinrich Heine University, 40225 Duesseldorf, Germany.
Ioannis SimiantonakisDepartment of Radiation Oncology, Heinrich Heine University, 40225 Duesseldorf, Germany.
Kai KammersDivision of Biostatistics and Bioinformatics, Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Christiane MatuschekDepartment of Radiation Oncology, Heinrich Heine University, 40225 Duesseldorf, Germany.
Heinrich Heine University Düsseldorf · DEJohns Hopkins University · USLMU Klinikum · DEUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PURPOSE/

objectiveAdjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, the whole breast was covered by two opposing tangential beams. Several randomized trials have tested partial breast irradiation (PBI) compared to whole breast irradiation (WBI) using different radiation techniques. There is evidence from randomized trials that PBI might result in lower mortality rates compared to WBI. We aimed to reassess this question using current data from randomized trials. MATERIAL/

methodsWe performed a systematic literature review searching for randomized trials comparing WBI and PBI in early stage breast cancer with publication dates after 2009. The meta-analysis was performed using the published event rates and the effect sizes for overall survival (OS), breast cancer-specific survival (BCSS), and non-breast cancer death (NBCD) as investigated endpoints. Analysis of subgroups using different radiation techniques was intended. We used hazard ratios (HR) and risk differences (RD) to estimate pooled effect sizes. Statistical analysis was performed using the inverse variance heterogeneity model.

resultsWe identified eleven studies randomizing between PBI and WBI. We did not find significant differences in OS (

conclusionIn contrast to a previous assessment of mortality, we could not find a detrimental effect of WBI on OS or NBCD. A longer follow-up might be necessary to fully assess the long-term mortality effects of PBI compared to WBI.

Indexed as

cancerinvestigationradiation therapyrandomizedstudy

Identifiers

PMID32824414
PMCPMC7464494
OpenAlexW3049481914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.